VHPB Centre for Evaluation of Vaccination (CEV) |
Executive Secretary Administrative and Scientific Secretariat |
privacy statement
|
March 19-21, 2014- Brasilia, Brasil
Objectives of the meeting:
Pre-meeting document 436KB (.pdf)
18.00 - 19.00 Registration
19.00 - 20.30
SESSION 1: Opening and objectives
Chair:
19.40 – 20.00
Viral hepatitis in Latin America and the Caribbean: a public health challenge - 1.6Mb(.pdf)
Massimo Ghidinelli , (PAHO)
20.00 – 20.20
The 2014 Brazilian Resolution at the World Health Assembly - 322KB(.pdf)
Fábio Mesquita , (BRA-MOH)
20.20 – 20.30 Q&A
20.20 Welcomes reception
PART I VIRAL HEPATITIS PREVENTION BOARD - VHPB
SESSION 2: Viral hepatitis prevention board - VHPB
Chair: Wolfgang Jilg(VHPB-Germany) and Joana Carvalho Costa (Technical advisor to the Department of sTD, AIDS and Viral hepatitis - Brazil)
09.00 – 09.20
Introduction of the VHPB - 2MB(.pdf)
Pierre Van Damme (VHPB, VAXINFECTIO - Antwerp, Belgium)
09.20 – 09.50
22 years VHPB: realisations and impact - 2MB(.pdf)
Mark Kane (VHPB Honorary member – USA) and Johannes Hallauer (VHPB – Germany)
Impact of VHPB meeting in a country
09.50 – 10.05
Portugal - 5MB(.pdf)
Rui Tato Marinho
10.05 – 10.20
Bulgaria - 615KB(.pdf)
Mira Kojouharova
10.45 – 11.05
Israel - 1MB(.pdf)
Daniel Shouval
10.35 – 10.45 Q&A
10.45 – 11.05 Coffee Break
SESSION 3: World Viral Hepatitis
Chair: Tatjana Reic (VHPB-ELPA) and Evaldo Stanislau (Medicine School of University of Sao Paulo-Brasil)
WHO Global Viral Hepatitis plan- 1.9 MB(.pdf)
Massimo Ghidinelli (Head of STD/AIDS, Hepatitis and Tuberculosis of the Pan American Health Organisation PAHO/ WHO)
09.50 – 10.10
World HepatitisAlliance – Patient point of view - 231KB (.pdf)
Charles Gore (World Hepatitis Alliance - WHA)
10.30 – 10.45 Q&A
10.45 – 11.05 Lunch
PART II OVERVIEW OF VIRAL HEPATITIS IN LATIN AMERICA
SESSION 4: Viral hepatitis Situation in Latin America
Chair: Rui Tato Marinho (VHPB-Portugal), Maria Cassia Mendes Correa (Medicine school of University of Sao Paolo-Brazil)
13.30 – 13.50
The Brazilian mathematical model - 1.4MB (.pdf)
Marcelo Nascimento Burattini (Medicine school of University of Sao Paolo-Brazil)
13.50 – 14.10
Treatment Guidelines of the Latin American Association for the Study of the Liver. -2.4MB (.pdf)
Nahum Méndez-Sánchez (Medical Sur. Clinic&Foundation-Mexico)
14.10 – 14.30
The burden of hepatocellular carcinoma related to viral hepatitis in LA. - 3.5MB (.pdf)
Raymundo Paraná (Representative of the Brazilian Society of Hepatology)
14.30 – 14.50
Liver transplantation in Latin America. 3.2MB (.pdf)
Paulo Celso Bosco Massarollo (Santa Casa de Misericordia from Sao Paulo-Brazil)
14.50 – 15.10 Q&A
15.10 – 15.45 Coffee Break
SESSION 5: Viral hepatitis issues in the different latin American Countries
Chair: Daniel Lavanchy (VHPB Honorary-Switzerland) and Marcelo Contardo Moscoso Naveira (Johns Hopkins, USA-Brazil)
15.45 – 16.05
Argentina - 3.3kB (.pdf)
Gabriela Vidiella (Argentine Ministry of Health)
16.05 – 16.25
Carribean - 748kB (.pdf)
Fernando A. Contreras Pena (Center for Adanced Gastroenterology- Chile)
16.25 – 16.45
Peru. - 3.9Mb (.pdf)
Carlos Manuel Benites Villafane (Peruvian Ministry of Health)
16.45 – 17.05 Discussion
SESSION 6: Face viral hepatitis control in Latin America
Chair: Daniel Shouval (VHPB-Israel), Themis Rebervel Silveira (Hospital SAnto Antonio-RS, Brazil)
17.05 – 17.25
Impact of the single-dose immunization strategy against hepatitis A in Argentina. - 4.1MB(.pdf)
Jorge Enrique Gonzalez ( National institute of infectious diseases - Argentina)
17.25– 17.40
Hepatitis E infection in Latin America - 3MB (.pdf)
Angelo Alves de Mattos (Latin American Association of the Study of the Liver)
17.40 – 18.00
Difficulty to implement an integrated Molecular Biology tool in Latin America. - 1.1MB (.pdf)
Andreas Stöcker (University Hospital Edgard Santos-Brazil)
18.00 – 18.20
The building of a viral hepatitis network in Latin America. - 1.7MB(.pdf)
Marcelo Silva (University Hospital Austral-Argentina)
18.20 – 18.40 Discussion
20.00 Meeting Dinner
PART III PREVENTION AND CONTROL OF VIRAL HEPATITIS IN BRAZIL
SESSION 7: Health Care system in Brazil
Chair: Mark Kane (VHPB Honorary-USA) and Denise Rinehart (CONASEMS-Brazil)
09.00 – 09.20
Organization of the public health system in Brazil. - 808KB(.pdf)
André Luis Bonifácio de Carvalho (Secretariat of Strategic and Participative Management, Ministry of Health, Brazil)
09:15 – 09:30
Burden of liver disease in Brazil . - 3.3MB(.pdf)
Angelo Alves de Mattos (Latin American Association of the Study of the Liver)
09.30 – 09.45
The Brazilian response to viral hepatitis /Brazilian Hepatitis Plan . - 258kB (.pdf)
Marcelo Contardo Moscoso Naveira (Johns Hopkins, USA-Brazil)
09.45 – 10.00
Brazilian vaccination program, coverage rates and vaccine manufacturing.
Paulo Lee Ho (Butantan Institute, Sao PAulo, Brazil)
10.00 – 10.15 Discussion
SESSION 8: Epidemiology and burden of viral hepatitis in Brazil
Chair: Angela Dominguez (VHPB-Spain) and Angelo Alves de Mattos (Latin American Association of the Study of the Liver)
10.15 – 10.30
Hepatitis A and E - 2.3MB (.pdf)
Themis Rebervel Silveira (Hospital Santo Antonio-RS, Brazil)
10.30 – 10.45
Epidemiological heterogeneity of infections with hepatitis B and D viruses in Brazil - 1.2MB(.pdf)
Gilberta Bensabath (Evandro Chagas Institure of Para, Brazil)
10.45 – 11.00
Hepatitis C - 2.4MB (.pdf)
Evaldo Stansilau (Medicine School of University of Sao Paulo-Brazil)
11.00 – 11.15 Discussion
11.15 – 11.30 Coffee Break
SESSION 9: Hepatitis in special risk groups/regions in Brazil
Chair: Heléne Norder (VHPB-Sweden) and Thor Oliveira Dantas (SAE/SESACRE-Brazil)
11.30 – 11.45
HIV and HBV/HCV co-infection - 432KB (.pdf)
João Silva de Mendonça (Department of infecious diseases HSPE- Brazil)
11.45 – 12.00
Particular matters of viral hepatitis in the Brazilian Amazon -3.5 MB (.pdf)
Juan Miguel Villalobos Salcedo (Fiocruz-RO, Brazil).
12.00 – 12.15
Molecular epidemiology of hepatitis C, B and D infection in Brazilian Amazonia - 2.8MB (.pdf)
Wornei Braga (Tropical Medicine Foundaton of Amazonas).
12.15 – 12.30 Discussion
12.30 – 14.15 Lunch
SESSION 10: Future Challenges
Chair: Pierre Van Damme (VHPB-Belgium) and Raymundo Paraná (Representative of the Brazilian Society of Hepatology)
14.15 – 14.30
Challenges for viral hepatitis prevention in Latin America - 875KB (.pdf)
Laura Alves De Souza (Technical Advisor of the Department of STD/AIDS and viral hepatitis-Brazil).
14.30 – 14:45
Challenges to care viral hepatitis patients in Latin America.- 1.4MB (.pdf)
Edison Parise (President of the Brazilian Society of Hepatology).
14.45 – 15.00
The role of civil society to define national response to viral hepatitis -1.9MB (.pdf)
Carlos Norberto Varaldo (Optimism Support Groups Hepatitis Carriers-Brazil).
15.00 – 15.15
Logistic problems to face delta hepatitis in the Amazonian countries - 1.4MB (.pdf)
Thor Oliveira Dantas (SAE/SESACRE-Brazil).
15.15 – 15.30
Cost of viral hepatitis treatment and challenges -966KB (.pdf)
Fábio Mesquita (Director of the Department of STD/AIDS and viral hepatitis-Brazil).
15.30 – 16.00 Q&A - meeting Discussion
16.00 – 16.30 Coffee Break
SESSION 11: Conclusions of the meeting
Chair: : Johannes Hallauer (VHPB-Germany) and Fábio Mesquita (Director of the Department of STD/AIDS and viral hepatitis-Brazil)
16.30 – 17.30
Presentation of the meeting conclusions - 58KB (.pdf)
David FitzSimons (Rapporteur).